MRC1 and Lynch syndrome: Consequently, tumors from patients with Lynch syndrome characteristically demonstrate MMR deficiency, defined as the presence of high microsatellite instability (MSI‐H) and/or the loss of MMR protein expression, which are the hallmarks of this disorder 37, 38.